JOSH'S STORY
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreAssessing the effects of a new class of leukaemia drug on normal myeloid leukocytes and lymphocytes this includes neutrophils, monocytes, eosinophils, basophils, T-cells, B-cells and natural killer cells. The project will produce valuable data regarding the targeted nature of this new therapeutic. The compound is a potent inducer of cell death in leukaemia cell lines and has recently been patented by the University of Salford. Its discovery and development has been funded, in part, by Kidscan for a number of years.
Grant Award – Kidscan Student Placement (2014 – 2015)
Funding Award – £1500.00
Funding Awarded to – Dr Lucy Smyth
Research Location – University of Salford
Lead Researcher – Dr Lucy Smyth
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreWhat a whopper of a night - Friday 20th May, our ambassador Isla's mum Jill and family hosted...
Read MoreWe want to say a huge thank you to Lee Mossop, former Captain of RFL Salford Red...
Read More